These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9220495)

  • 21. Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts.
    Bradley K; Scatizzi JC; Fiore S; Shamiyeh E; Koch AE; Firestein GS; Gorges LL; Kuntsman K; Pope RM; Moore TL; Han J; Perlman H
    Arthritis Rheum; 2004 Jan; 50(1):78-87. PubMed ID: 14730602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.
    Burger D; Rezzonico R; Li JM; Modoux C; Pierce RA; Welgus HG; Dayer JM
    Arthritis Rheum; 1998 Oct; 41(10):1748-59. PubMed ID: 9778216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocarcinoma cell lines down-regulate matrix metalloproteinase-2 expression in human hepatic myofibroblasts.
    Blanc JF; Bisson C; Frankenne F; Noël A; Munaut C; Colige A; Collette J; Rosenbaum J; Foidart JM
    Int J Oncol; 2002 Jun; 20(6):1129-36. PubMed ID: 12011989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
    Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
    Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: Upregulation in response to sulphur mustard.
    Ries C; Popp T; Egea V; Kehe K; Jochum M
    Toxicology; 2009 Sep; 263(1):26-31. PubMed ID: 18809459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts.
    Saad S; Gottlieb DJ; Bradstock KF; Overall CM; Bendall LJ
    Cancer Res; 2002 Jan; 62(1):283-9. PubMed ID: 11782389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
    Isaka K; Nishi H; Nakai H; Nakada T; Feng Li Y; Ebihara Y; Takayama M
    Cancer; 2003 Jan; 97(1):79-89. PubMed ID: 12491508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases.
    Segain JP; Harb J; Grégoire M; Meflah K; Menanteau J
    Cancer Res; 1996 Dec; 56(23):5506-12. PubMed ID: 8968108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tranilast (N-3,4-dimethoxycinamoyl anthranilic acid): a novel inhibitor of invasion-stimulating interaction between gastric cancer cells and orthotopic fibroblasts.
    Yashiro M; Murahashi K; Matsuoka T; Nakazawa K; Tanaka H; Osaka H; Koyama T; Ohira M; Chung KH
    Anticancer Res; 2003; 23(5A):3899-904. PubMed ID: 14666694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
    Jones JL; Shaw JA; Pringle JH; Walker RA
    J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion.
    Stearns ME; Rhim J; Wang M
    Clin Cancer Res; 1999 Jan; 5(1):189-96. PubMed ID: 9918218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.
    Hagemann T; Robinson SC; Schulz M; Trümper L; Balkwill FR; Binder C
    Carcinogenesis; 2004 Aug; 25(8):1543-9. PubMed ID: 15044327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma.
    Cao Z; Xiang J; Li C
    Int J Oral Maxillofac Surg; 2009 Aug; 38(8):880-5. PubMed ID: 19372030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.